Abstract

Clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated (Cas) RNA-guided nucleases (RGNs) have been broadly adopted by the scientific community for use as robust genome editing tools. However, CRISPR-Cas RGNs have been demonstrated to exhibit high-frequency off-targets at sites with up to 5 mismatches from the intended target site, raising questions about their global specificity. We have developed a novel method called GUIDE-seq (for Genome-wide Unbiased Identification of DSBs enabled by Sequencing), based on the efficient integration of a double-stranded oligodeoxynucleotide (dsODN) tag followed by tag-specific amplification and high-throughput sequencing. We performed GUIDE-seq on 10 RGNs in 2 human cell lines and identified all known off-target cleavage sites of these RGNs as well as hundreds of additional novel sites. The number of off-target cleavage sites identified varied widely among these RGNs, and the majority of identified sites were not predicted by existing computational methods or ChIP-seq. GUIDE-seq provides a robust method for evaluating the genome-wide specificities of RGNs that will be useful for the clinical translation of these important and widely applicable genome editing reagents.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.